Smith & Nephew plc (LON:SN) Receives GBX 1,382.63 Consensus Target Price from Brokerages

Shares of Smith & Nephew plc (LON:SN) have received a consensus recommendation of “Hold” from the eight brokerages that are currently covering the company, MarketBeat reports. Five investment analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average 1 year target price among analysts that have issued a report on the stock in the last year is GBX 1,382.63.

Several research firms recently commented on SN. Jefferies Financial Group reiterated a “buy” rating and set a GBX 2,760 target price on shares of Smith & Nephew in a research report on Thursday, May 21st. UBS Group reiterated a “neutral” rating and set a GBX 1,300 target price on shares of Smith & Nephew in a research report on Tuesday, May 5th. Berenberg Bank reiterated a “hold” rating and set a GBX 13 target price on shares of Smith & Nephew in a research report on Friday, May 1st. Finally, Royal Bank Of Canada reiterated a “sector perform” rating and set a GBX 1,350 target price on shares of Smith & Nephew in a research report on Wednesday, June 10th.

Smith & Nephew Price Performance

LON:SN opened at GBX 1,133 on Monday. The stock’s 50 day simple moving average is GBX 1,161.09 and its 200 day simple moving average is GBX 1,219.98. The company has a current ratio of 2.57, a quick ratio of 0.84 and a debt-to-equity ratio of 62.90. The firm has a market cap of £12.42 billion, a P/E ratio of 40.79, a PEG ratio of 0.46 and a beta of 0.67.

Smith & Nephew Company Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.